Ignite Creation Date:
2024-10-25 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06562647
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-15
Brief Title:
SY001 Targets Mesothelin in a Single-arm Dose-increasing Setting in Subjects With Advanced Solid Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An Exploratory Clinical Trial to Evaluate the Safety Tolerability Pharmacokinetics and Initial Efficacy of SY001 Injection Targets Mesothelin in a Single-arm Dose-increasing Setting in Subjects With Advanced Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Single-arm dose-increasing setting study of CAR macrophages in Mesothelin overexpressing solid tumors
Detailed Description:
This study was a single-arm single-center dose-increasing design using the 33 approach for dose escalation to evaluate the safety tolerability and initial effectiveness of SY001 and to evaluate the pharmacokinetic characteristics cytokines and the correlation between the efficacy of SY001
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None